drugset / Trial / NCT05629338
Ascending Dose Study of FrontlineODP™ Spray Dried Plasma
RandomizedCrossoverQuadruple-blindOther
Summary
This study in healthy volunteers is designed to assess the safety of infusing increasing doses of spray dried plasma (FrontlineODP).
Timeline
- Start
- 2022-12-01
- Primary completion
- 2025-03-18
- Completion
- 2025-04-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous Spray Dried Plasma | Unknown | 200 ml | — |
| Subject | Autologous Spray Dried Plasma | Unknown | 400 ml | — |
| Subject | Autologous Spray Dried Plasma | Unknown | 800 ml | — |